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Abstract
After menopause, many women experience vaginal dryness and atrophy of tissue, often attributed to the loss of estrogen.
An understudied aspect of vaginal health in women who experience dryness due to atrophy is the role of the resident
microbes. It is known that the microbiota has an important role in healthy vaginal homeostasis, including maintaining the
pH balance and excluding pathogens. The objectives of this study were twofold: first to identify the microbiome of post-
menopausal women with and without vaginal dryness and symptoms of atrophy; and secondly to examine any differences
in epithelial gene expression associated with atrophy. The vaginal microbiome of 32 post-menopausal women was profiled
using Illumina sequencing of the V6 region of the 16S rRNA gene. Sixteen subjects were selected for follow-up sampling
every two weeks for 10 weeks. In addition, 10 epithelial RNA samples (6 healthy and 4 experiencing vaginal dryness) were
acquired for gene expression analysis by Affymetrix Human Gene array. The microbiota abundance profiles were relatively
stable over 10 weeks compared to previously published data on premenopausal women. There was an inverse correlation
between Lactobacillus ratio and dryness and an increased bacterial diversity in women experiencing moderate to severe
vaginal dryness. In healthy participants, Lactobacillus iners and L. crispatus were generally the most abundant, countering
the long-held view that lactobacilli are absent or depleted in menopause. Vaginal dryness and atrophy were associated with
down-regulation of human genes involved in maintenance of epithelial structure and barrier function, while those
associated with inflammation were up-regulated consistent with the adverse clinical presentation.
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Introduction
The onset of menopause is accompanied by a dramatic increase
in reported symptoms of vaginal dryness, soreness, irritation or
itching, pain with intercourse and bleeding after intercourse [1].
Collectively these symptoms affect 25–50% post-menopausal
women [2,3] and significantly impact their quality of life.
Vulvovaginal atrophy (VVA) is somewhat of a catchment term
for these symptoms and is diagnosed by an assessment of vaginal
dryness, irritation, soreness, and dyspareunia with urinary
frequency, urgency, incontinence, and the presence of pale and
dry vulvovaginal mucosa with petechiae, along with pH.4.6 [4].
Though the use of estrogen replacement therapy (ERT) can
rapidly reverse some of these changes [5], a large proportion of
women are hesitant to use estrogens, even when applied topically
[3]. Interestingly, a proportion of women appear to remain
symptom free, long after the onset of menopause.
A lactobacilli-dominated vaginal microbiota is associated with
retention of health, but with menopause it has long been assumed
that ERT is required to maintain the dominant lactobacilli and
reduce the risk of infection [5]. This is supported by studies of the
vaginal microbiota using denaturing gel electrophoresis [6,7]. Next-
generation deep sequencing provides a means to uncover the extent
of bacterial presence in a given niche, including the vagina [8–10].
The aim of the present study was to identify the vaginal
microbiome of post-menopausal women who were clinically
healthy or had vaginal dryness, and examine any differences in
epithelial gene expression.
Results
The reported and observed vaginal symptoms are presented in
Figure S1. The observed vaginal dryness correlated well with
observed atrophy (r2 = 0.84) supporting vaginal dryness as an
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appropriate proxy for the occurrence of vaginal atrophy.
Moderate to severe scores were in agreement for three out of
the four measures that included of dryness, discoloration,
blanching and petechiae in 11 participants.
Illumina sequencing resulted in 1,758,430 total V6 reads after
quality filtering, with an average of 1741069917 reads per sample
(range: 2,123–53,054). Figure 1 shows the microbiota findings for
the 32 participants. Using a cutoff of 1% abundance in any
sample, there were 119 distinct operational taxonomic units
(OTUs) detected, each representing a bacterial taxa (Table S1).
Sixteen of the 32 participants were selected at their initial visit
and followed for microbiota samples every 2 weeks for 10 weeks
total. This time series showed that the microbiome abundance
profiles did not fluctuate greatly within a subject (Figure 2). When
a linear mixed effect model was applied to the Shannon’s
diversity index data, a statistical linear trend was not observed (p-
value = 0.364) indicating that the abundance of microbial
diversity from week to week did not change significantly within
a subject. The biotas of women who were least symptomatic
(‘none’ or ‘mild’ dryness score) had low bacterial diversity with a
dominance of lactobacilli (Figure 1 and 2). Conversely, women
with ‘moderate’ or ‘severe’ dryness had a decreased abundance of
lactobacilli and a large diversity in number of species detected. In
this latter group, there was a high representation of Prevotella
timonensis (OTU_6), Porphyromonas (OTU_9), Peptoniphilus
(OTU_27), and Bacillus (OTU_34) using a Mann-Whitney-
Wilcoxen rank-sum test (Figure S2). A weighted least squares
model was applied to the data and a statistical linear trend was
observed (p-value = 0.00141) indicating an inverse correlation
between Lactobacillus ratio and dryness.
Lactobacilli were dominant in many women, irrespective of age
(participant 13 age 74 versus participant 6 age 42), and the
absence of ERT. We noted lactobacilli at an abundance of $10%
in 29/32 (91%) women at time zero, while 17/32 (53%) had
lactobacilli as the overall dominating organism (greater than 50%
relative abundance).
In order to perform human genomic array analysis, one sample
was collected at random from each subject. Based upon successful
high-quality RNA isolation, 10 resulting samples were divided into
healthy controls and subjects experiencing dryness based upon
their observed dryness scores (Figure 2).
After importing intensity data into Partek GS 6.5, an ANOVA
was applied to identify differentially expressed genes between the
control and dryness groups. The list of genes was filtered to only
include those differentially expressed by at least 2-fold (p,0.05),
which yielded a list of 960 probe sets used for subsequent
comparative analyses (Table S2). A heatmap of the filtered list
(Figure 3) shows two main branches separating the dryness and
control groups. Participant 4 had an intermediate gene expression
profile between the dryness and control groups despite having no
self-reported or observed signs of dryness and correspondingly no
additional signs of atrophy.
Figure 1. Microbiota profiles for 32 post-menopausal women clustered by biota similarity. Each bar represents a single vaginal sample,
and the colored segments represent the relative fraction of each bacterial taxon detected at 1% relative abundance or greater in any one sample.
Sequences at less than 1% abundance have been included in the ‘‘remainder’’ fraction at the top of the bar (see color legend of bacterial taxa). The
microbiota are clustered by similarity as represented in the dendogram above. The sample name (participant ID-time point) is labeled in the
dendogram and corresponds to the bar below. The dryness score as observed by the examining nurse is represented below each microbiota bar.
doi:10.1371/journal.pone.0026602.g001
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Then, the top 20 genes in either direction with the greatest fold
change between the dryness and control groups were further
analyzed (Table 1) to determine where the most dramatic changes
occurred. The most up-regulated genes in the dryness group were
MMP7 (13.75-fold), and the choline transporter SLC44A4 which
was interrogated by three separate probe sets, all up-regulated
9.19-fold with identical p-values. The most down-regulated genes
in the dryness group were SPINK7 (238.65-fold) and TGM3
(221.86-fold).
To assess the relationship of differentially expressed genes, a
GeneOntology (GO) enrichment analysis of the filtered list of 960
probe sets was performed using Partek GS 6.5. The top 10 GO-
functions enriched are displayed in Table 2, and demonstrate
changes in epithelial remodeling and immune response. Cornified
envelope had the highest enrichment score with 62.50% (10 genes)
in this process and was down-regulated in the dryness group.
Discussion
The microbiota of this set of post-menopausal women was quite
stable with one out of a possible 62 transitions between normal and
BV Nugent scores, unlike another study of pre-menopausal
women that observed 226 transitions out of a possible 1365
opportunities (p=0.003) [11]. If indeed further studies confirm
that the microbial profiles of post-menopausal women are
relatively stable, perhaps it is due to lack of menstruation which
is known to cause stage-dependent variations in the microbiota
[12].
The Illumina sequencing method identified double or triple the
number of bacterial types per subject compared to previous gel
electrophoresis methods [7]. Similar to recent deep sequencing
studies of pre-menopausal women [8–10,13,14], we noted
Lactobacillus iners and Gardnerella vaginalis were universally present
and possibly represent core members in this niche. However, there
were much lower abundances (,1%) of Mobiluncus, Staphylococcus,
Sneathia, Bifidobacterium, and Gemella in our study set of post-
menopausal women. This could be due to our smaller sample size
rather than micro-environmental changes associated with meno-
pause, and so the physiological significance is not known. As more
information emerges about the different organisms in the
microbiota, the types of clones and virulence properties of them,
for example differences in expression of various toxins and mucus-
degrading enzymes by G. vaginalis [15], the better will be our
understanding of which strains equate to health versus disease.
Vaginal dryness, a condition that is associated with significant
changes in the transcription of genes associated with cellular
structure and immune function, as shown here by the human
microarray data, is a symptom of atrophy which afflicts large
numbers of menopausal women and has been linked with
depletion of estrogen [16]. The muscular layer of the vaginal wall
tends to be thicker in postmenopausal than premenopausal
women, while the epithelial layer is much thinner [17]. Having
developed a method to use Affymetrix arrays to read epithelial cell
gene expression changes in the vagina [18], we applied this here
and found down-regulation of genes involved in maintaining
proliferation and barrier function of the vaginal epithelium in the
dryness group. Without a cornified envelope, epithelial cells are
much more sensitive to drying, chemical agents and microbial
infection [19]. Many of the genes in this group encode structural
components of the cornified envelope, so lowered expression in the
dryness group implies reduced structural integrity of the tissue.
This is mirrored in the down-regulation of adhesion molecules
such as SBSN and DSG1, implicated in maintaining proper
epithelial barrier function [20,21]. Similarly, ALOX 12 (219.61-
fold) has also been shown to be a positive regulator of epidermal
barrier function [22], and keratin is an important structural
molecule in the epidermis imparting mechanical stability to the
tissue [23].
The most down-regulated gene in the dryness group was
SPINK7 (alias ECRG2), a member of the SPINK family of
proteases, which is known to regulate invasion and migration by
preventing extracellular matrix (ECM) degradation through
Figure 2. Time-series microbiota profiles for 16 post-menopausal sampled every 2 weeks. Each bar represents a single vaginal sample,
and each cluster of bars is a single participant (starting at time 0 and sampled every 2 weeks for up to 10 weeks total). The colored segments
represent the relative fraction of each bacterial taxon detected at 1% relative abundance or greater. Sequences at less than 1% abundance have been
included in the ‘‘remainder’’ fraction at the top of the bar (see color legend of bacterial taxa). The dryness score as observed by the examining nurse is
represented below each microbiota bar. Sample time points that were included in the microarray analysis are marked with an arrowhead: the first six
green arrows are controls (no or mild dryness), and the last four red arrows are women experiencing moderate to severe dryness.
doi:10.1371/journal.pone.0026602.g002
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inhibiting the action of urokinase-type plasminogen activator [24].
Matrilysin-1 protein (MMP) 7 opposes the SPINK family proteins,
and its up-regulation by 13.75-fold and cleaves ECM components
and up-regulate inflammation [25]. Thus, it is possible that the
combination of increased ECM degradation with decreased
inhibition of protease inhibitors contributes to vaginal thinning.
Both complement factors B and H (CFB and CFH) and other
components of the complement system were up-regulated in the
dryness group. Since dryness is accompanied by inflammation, this
suggests that the up-regulation of the regulatory molecules (CFH
and CFI), although perhaps capable of protecting host cells, are
not sufficient to dampen the inflammatory response. This potential
for dysregulation of the complement system in vaginal dryness
warrants further study. The transition from a lactobacilli
dominated microbiota to one dominated by Gram negative
anaerobes, Atopobium and Gram positive cocci could play a role in
the inflammatory process, but further studies would be needed to
prove the correlation in this environment rich in immune
mediators [26].
Differential expression of many cytokines and chemokines, the
messengers of inflammation and chemotaxis, was noted. Three
CXCL-family chemokines, known to recruit monocytes and
leukocytes to the vaginal epithelium, were observed to be up-
regulated 4.11 to 6.5 fold in the dryness group. Polymeric
immunoglobulin receptor (PIGR) was up-regulated 8.64-fold in
the dryness group; indicative of increased mucosal immune
activity.
Two highly up-regulated genes, SLC44A4 and PLAT, could be
associated with the symptoms of vaginal dryness and atrophy. The
SLC44A4 gene product is a sodium-dependent transmembrane
transport protein involved in the uptake of choline in neurons,
which is used in neurons in the production of acetylcholine, which
is one of the main neurotransmitters of the parasympathic nervous
system [27]. As the vaginal epithelium is rich in nerve endings and
these can increase in density with reduced estrogen, it is possible
that increased activity of this transporter may contribute to the
sensation of pain through cholinergic nerve endings. The PLAT
gene product is a serine protease which converts plasminogen to
plasmin, and functions in cell migration and tissue remodeling as
well as reducing blood clotting. Up-regulation of this gene may
play a role in the increased bleeding and tissue sensitivity
associated with vaginal dryness.
Our gene array findings agree with data obtained by Cotreau
et al. [28] on vaginal biopsies from 19 women with vulvovaginal
atrophy (VVA) before and after treatment with 17b-estradiol. The
similarity in results suggests that many of the genes being
differentially regulated between dryness and healthy women may
be as a result of differential estrogen levels between the groups.
This is further supported by the up-regulation of one of the vaginal
epithelial cornified envelope genes (LCE3D) following estrogen
replacement therapy [29], that was 14-fold down-regulated in
women with vaginal dryness.
In summary, the vaginal microbiota of 32 post-menopausal
women identified 119 OTUs and subset analysis showed little
fluctuation over time, unlike that of pre-menopausal women
reported previously. There was an inverse correlation between
Lactobacillus ratio and dryness, a condition commonly found after
menopause, which shown here to be associated with changes in
vaginal epithelial cell integrity and inflammation.
Methods
Study population
The institutional review board of the University of Western
Ontario, London, Canada, approved the protocol. The study,
albeit not a clinical trial, was nevertheless registered at
clinicaltrials.gov with ID# NCT01084616 for full disclosure.
From a practice with over 500 post-menopausal women, a total
of 32 between ages 42 and 77 were identified and recruited at the
Victoria Family Medical Center in London, Canada between
January and February 2010, and followed until June 2010.
Participants were recruited to the study by their physician (Jo-
Anne Hammond), or information sheets posted in doctor’s offices.
All had at least 12 months of amenorrhea, had not used antibiotics
or had any vaginal infection one month prior to screening, had not
used systemically estrogen products 6 months prior to sampling, or
topical estrogen containing product one week before sampling.
Women were excluded if they had used douches or lubricants in
the past week.
After giving informed consent, each participant completed a
questionnaire on demographics, history of vaginal or urinary tract
symptoms or infections, and a self-assessment of the severity of five
vaginal symptoms: vaginal dryness, vaginal irritation or itching,
pain during urination not associated with infection, vaginal
soreness, pain during sexual intercourse, bleeding after sexual
intercourse. Symptoms were rated as none, mild, moderate or
Figure 3. Heatmap of vaginal epithelial gene expression of 10
samples. A clustered heatmap of differential gene expression (.2-fold
change, p,0.05) between the control and dryness groups. Samples are
labeled as participant number-time point (week). Samples assigned to
the dryness or control groups based on physiological examination of
the vagina are well separated by gene expression differences with
exception of 4–8 which has an intermediate gene expression profile
and clusters closer to the dryness group.
doi:10.1371/journal.pone.0026602.g003
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severe. Pain with intercourse and bleeding after intercourse could
be scored as ‘‘not applicable’’.
A gynecologic examination was performed by a nurse trained to
detect dryness and atrophy to provide an ‘observed’ assessment of
vaginal color, dryness, blanching and integrity of tissue, vaginal
tissue petechiae, and overall vaginal atrophy. Vaginal pH was
measured using the pHem-Alert indicator (Gynex, Wyoming,
USA). A cytobrush (Cytobrush plus GT, Cooper Surgical Inc.
USA) was used to collect epithelial cells from the mid-vagina for
human mRNA analysis. The cytobrush was immediately placed in
a 1.5 ml sterile RNase-free microtube containing 700 ml RNAlater
stabilization agent (Applied Biosystems, Austin, Texas, USA) and
stored at 4uC within 4 hours of collection. RNA extraction
occurred within 72 hours of collection. Two polyester Dacron
swabs were used to sample the mid-vagina for microbial analysis:
one was archived at 280uC for later bacterial DNA extraction,
and the other was rolled on a microscope glass slide and scored for
bacterial vaginosis (BV) using the Nugent criteria [30]. Sixteen
Table 1. The top 20 genes up- and down- regulated genes (p,0.05) in the vaginal dryness group compared to controls.
Gene Symbol Gene Assignment RefSeq ID p-value Fold Change
MMP7 matrix metallopeptidase 7 (matrilysin, uterine) NM_002423 7.73E-03 13.75
SLC44A4 solute carrier family 44, member 4 NM_025257 2.23E-02 9.19
SLC44A4 solute carrier family 44, member 4 NM_025257 2.23E-02 9.19
SLC44A4 solute carrier family 44, member 4 NM_025257 2.23E-02 9.19
CFH complement factor H NM_000186 4.79E-03 8.72
PIGR polymeric immunoglobulin receptor NM_002644 2.01E-02 8.64
IL19 interleukin 19 NM_153758 3.25E-02 8.31
Transcript ID: 8158684 9.50E-03 8.28
Transcript ID: 8180303 2.26E-02 7.73
CFB complement factor B NM_001710 4.69E-02 7.33
PLAT plasminogen activator, tissue NM_000930 2.23E-02 7.19
Transcript ID: 8138487 2.08E-03 7.10
CFB complement factor B NM_001710 4.78E-02 6.93
WFDC2 WAP four-disulfide core domain 2 NM_006103 8.32E-03 6.61
CXCL6 chemokine (C-X-C motif) ligand 6 NM_002993 1.81E-02 6.50
TSPAN1 tetraspanin 1 NM_005727 2.46E-02 6.30
AGR2 anterior gradient homolog 2 (Xenopus laevis) NM_006408 1.50E-02 6.18
TRIM31 tripartite motif-containing 31 NM_007028 4.77E-02 5.85
ASS1 argininosuccinate synthetase 1 NM_000050 3.05E-03 5.70
PLAC8 placenta-specific 8 NM_016619 2.03E-02 5.51
SPINK7 serine peptidase inhibitor, Kazal type 7 (putative) NM_032566 4.81E-04 238.65
TGM3 transglutaminase 3 NM_003245 4.24E-05 221.86
SBSN Suprabasin, part of a gene complex including dermokine NM_198538 3.28E-05 220.93
ALOX12 arachidonate 12-lipoxygenase NM_000697 4.43E-04 219.61
KPRP keratinocyte proline-rich protein NM_001025231 2.30E-04 217.43
GYS2 glycogen synthase 2 (liver) NM_021957 1.66E-03 216.78
DSG1 desmoglein 1 NM_001942 5.02E-03 216.61
LCE3E late cornified envelope 3E NM_178435 6.78E-04 215.35
LCE3D late cornified envelope 3D NM_032563 3.27E-03 214.61
SERPINB12 serpin peptidase inhibitor, clade B NM_080474 1.42E-03 214.11
PNLIPRP3 pancreatic lipase-related protein 3 NM_001011709 3.06E-04 213.69
KRTDAP keratinocyte differentiation-associated protein NM_207392 2.16E-03 213.08
CLDN17 claudin 17 NM_012131 1.99E-03 212.88
KRT1 keratin 1 NM_006121 1.16E-03 211.99
LOC441178 hypothetical LOC441178 AL832737 4.66E-03 210.89
LOC441178 hypothetical LOC441178 AL832737 4.66E-03 210.89
ME1 malic enzyme 1, NADP(+)-dependent, cytosolic NM_002395 1.32E-03 210.57
Transcript ID: 8020347 1.70E-03 210.26
CRCT1 cysteine-rich C-terminal 1 NM_019060 3.86E-03 29.80
CRISP3 cysteine-rich secretory protein 3 NM_006061 8.76E-03 29.75
doi:10.1371/journal.pone.0026602.t001
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participants with moderate to severe vaginal dryness were followed
every 2 weeks for up to 10 weeks total.
Bacterial DNA extraction, amplification, and sequencing
Bacterial DNA was extracted using Instagene (Bio-Rad) and the
V6 region of the 16 s rRNA gene was PCR amplified as described
previously [9] using barcoded primers: L-V6 (59-CAACGCGAR-
GAACCTTACC-39) and R-V6 (59-ACAACACGAGCTGAC-
GAC-39). Based on the intensity of the ethidium bromide-stained
band on an agarose gel, an approximate equimolar ratio of PCR
products were mixed together to give the final sample sent for
Illumina paired-end sequencing at The Centre for Applied
Genomics in Toronto, Canada.
OTU clustering and taxonomic assignment
Sequence filtering, processing, and microbial analysis was
performed as described previously [9,31] and summarized as
follows. After overlapping paired reads to get full-length V6
sequence, the reads were clustered at 95% nt identity using Uclust
version 3.0.617 (http://www.drive5.com/usearch/index.html).
The most abundant sequence in a cluster was selected as a
representative OTU. Taxonomic assignments for the representa-
tive OTUs were made through alignments against the Greengenes
[32] database using NAST [33] and further manual curation by
BLAST to the NCBI non-redundant database. The representative
OTU sequences occurring with at least 1% abundance in any one
sample have been deposited in GenBank under accession numbers
JF262791–JF262909. OTU taxonomic assignments are presented
in Table S1.
Vaginal epithelial RNA extraction
Each of the 32 subjects provided a single sample for human
genomic array. Vaginal cytobrush samples were centrifuged
(50006g, 10 min, 4uC) and the supernatant was discarded before
RNA extraction by TRIzol following the manufacturer’s protocol
(Invitrogen, Carlsbad, CA, USA). The pellet was resuspended in
20 ml RNase-free water and stored at280uC until further analysis.
RNA quantity and quality was assessed by a Nanodrop 2000c
spectrophotometer (Thermo Fisher Scientific, Waltham, MA,
USA) to ensure a 260 nm/280 nm ratio above 1.8 and a 260 nm/
230 nm ratio above 1.4 before quality was confirmed using an
Agilent 2100 Bioanalyzer (Agilent technologies, Santa Clara, CA,
USA). All steps of GeneChip probe preparation and hybridization
were performed by the LRGC using standard protocols. All liquid
handling steps were performed by a GeneChip Fluidics Station
450 and GeneChips were scanned with the GeneChip Scanner
3000 7G (Affymetrix, Santa Clara, CA) using Command Console
v1.1.
Sufficient quality and quantity of RNA was received from 10 of
the samples, four from the dryness group (age 57.068.9 years:
range: 50–70 years, with an average 13.3611.4 years since last
menses: range: 3–21 years). and six from the subjects with a
normal Nugent score (age 56.269.3 years; range: 48–74 years,
with an average time since last menses of 11.369.8 years: range:
6–30 years).
Gene expression analysis
Probe level (.CEL file) data was generated using Affymetrix
Command Console v1.1. Probes were summarized to gene level
data in Partek Genomics Suite v6.5 (Partek, St. Louis, MO) using
the RMA algorithm [34].
Gene expression data has been deposited in the Gene Expression
Omnibus Database under accession number GSE26761 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=hpatrkqyqcqmulk&
acc=GSE26761).
Statistics
Shannon’s diversity index [35] was calculated for each subject at
each time point as the abundance values of 119 operational
taxonomic units (OTUs). The Shannon’s diversity index (S) was
defined as as S~{
P
pi log(pi) where pi denotes the proportional
abundance values at the ith OTU in each sample. The Lactobacillus
ratio was calculated for each subject at each time point, as the ratio
of total abundance value for the Lactobacillus OTUs versus all the
OTUs.
Hierarchical clustering was performed by calculating the
Euclidean distance between microbiota samples using the hclust
function in R [36] and the similarity is plotted in a dendogram in
Figure 1.
To determine if the linear trends in the S trajectories differ
significantly across subjects, the following linear mixed effect
model [37] was applied to the data Yit~mzaizbitzeit. The
fixed effect being the intercept only and random effects being
subject intercepts and slopes where Yit denoted the S value of
subject i at time point t and m is an unknown fixed constant, ai is a
random subject intercept, bi a random subject slope, and ai, bi, eit
are independent normal random variables.
Table 2. Enrichment of GO terms in the filtered gene list (n = 960).
Function GO ID
Enrichment
Score
Enrichment p-
value No. of Genes
% of total genes in GO term
group differentially expressed
Cornified envelope 1533 21.81 3.37E-10 10 62.50
Keratinocyte differentiation 30216 20.01 2.04E-09 11 47.83
Immune response 6955 19.20 4.60E-09 38 13.52
Cell differentiation 30154 17.96 1.59E-08 24 17.91
Epidermis development 8544 17.55 2.38E-08 17 23.94
Tissue development 9888 17.48 2.55E-08 23 18.11
Cellular developmental process 48869 15.29 2.28E-07 30 13.45
Extracellular region 5576 13.99 8.37E-07 37 11.28
Epithelial cell differentiation 30855 13.12 2.01E-06 6 60.00
Innate immune response 45087 13.03 2.18E-06 11 26.83
doi:10.1371/journal.pone.0026602.t002
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In order to determine if a statistical relationship existed between
microbial diversity and vaginal dryness, a weighted least squares
analysis [38] was applied to the data. Observed dryness scores of
‘‘none’’, ‘‘mild’’, ‘‘moderate’’, and ‘‘severe’’ were treated as ordinal
values 0, 1, 2, and 3, respectively. The weighted least squares
model Yid~m0zm1dzeid was used to test the linear effect of
observed dryness with respect to microbial diversity. Where Yid
denotes the average S of subject i at dryness d. The quantities m0
and m1d are constants representing intercept and slope respec-
tively. We also applied the Mann-Whitney-Wilcoxen rank-sum to
the OTUs by comparing the relative abundances between women
with and without dryness at timepoint 0.
Supporting Information
Figure S1 A heatmap representing the scored vaginal
dryness and atrophy. The symptoms were self-reported by the
participants via a questionnaire, and also reported as observed by
the nurse upon examination of the vagina. Atrophy was an overall
subjective score by the nurse based on all clinical observations,
smoothness was scored as a lack of rugosity, irritation represents
symptoms of vaginal irritation and itching. PDI - pain during
intercourse.
(PDF)
Figure S2 Relative abundances of each OTU for sam-
ples at time point 0 with and without vaginal dryness.
Each plot represents a single OTU and the relative abundance
(fraction of microbiota) for each time point 0 sample is plotted on
the y-axis. The samples are divided into two groups based on the
nurse’s observation: women without vaginal dryness (none or mild)
and women with vaginal dryness (moderate or severe). The p-
value represents the result of the Mann-Whitney-Wilcoxen rank-
sum test on the relative OTU abundances between the dry and
non-dry groups.
(PDF)
Table S1 Taxonomic assignments to OTUs at $1%
relative abundance in any one sample. Assignments were
made using the Greengenes database [32] and manually validated
by BLAST [39] to the NCBI non-redundant database.
(PDF)
Table S2 Affymetrix read outs for 960 probe sets
representing those differentially expressed by at least
2-fold.
(PDF)
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